Vaccines continue to play an essential role in the fight against the coronavirus as the emergence of new variants, including omicron, has reduced the effectiveness of antibody cocktail treatments, and oral antiviral supply is just beginning to ramp up. We think a certain number of high-risk individuals will continue to contract COVID-19 each year for the foreseeable future, requiring treatment.